Liquid Tasimelteon Formulations and Methods of Use Thereof
US-2026007633-A1 · Jan 8, 2026 · US
This page is not indexed by search engines while we improve data quality.
Phadke Deepak patents
Phadke Deepak is listed as an inventor on 45 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Phadke Deepak |
| Total patents | 45 |
| First publication | Feb 12, 2015 |
| Latest publication | Jan 8, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Liquid tasimelteon formulations and methods of use thereof
US-12447141-B2 · Oct 21, 2025 · US
Highly purified pharmaceutical grade tasimelteon
US-2025320188-A1 · Oct 16, 2025 · US
Liquid tasimelteon formulations and methods of use thereof
US-12440470-B2 · Oct 14, 2025 · US
Highly purified pharmaceutical grade tasimelteon
US-12304896-B2 · May 20, 2025 · US
Liquid Tasimelteon Formulations and Methods of Use Thereof
US-2025090492-A1 · Mar 20, 2025 · US
Highly purified pharmaceutical grade tasimelteon
US-2024336584-A1 · Oct 10, 2024 · US
Melatonin agonist treatment
US-2024325339-A1 · Oct 3, 2024 · US
Highly purified pharmaceutical grade tasimelteon
US-12049457-B2 · Jul 30, 2024 · US
Iloperidone metabolite for use in the treatment of psychiatric disorders
US-2024016791-A1 · Jan 18, 2024 · US
Recent patents
Latest publications not already listed above.
Highly purified pharmaceutical grade tasimelteon
US-2023382883-A1 · Nov 30, 2023 · US
Liquid Tasimelteon Formulations and Methods of Use Thereof
US-2023372285-A1 · Nov 23, 2023 · US
Liquid tasimelteon formulations and methods of use thereof
US-11759446-B2 · Sep 19, 2023 · US
Highly purified pharmaceutical grade tasimelteon
US-11760740-B2 · Sep 19, 2023 · US
Highly purified pharmaceutical grade tasimelteon
US-2023150964-A1 · May 18, 2023 · US
Highly purified pharmaceutical grade tasimelteon
US-11566011-B2 · Jan 31, 2023 · US
Ophthalmic Pharmaceutical Compositions
US-2023026577-A1 · Jan 26, 2023 · US
Melatonin agonist treatment
US-2023021493-A1 · Jan 26, 2023 · US
Highly purified pharmaceutical grade tasimelteon
US-2022073482-A1 · Mar 10, 2022 · US
Highly purified pharmaceutical grade tasimelteon
US-11203581-B2 · Dec 21, 2021 · US
Liquid tasimelteon formulations and methods of use thereof
US-11202770-B2 · Dec 21, 2021 · US
Liquid Tasimelteon Formulations and Methods of Use Thereof
US-2021212980-A1 · Jul 15, 2021 · US
Liquid Tasimelteon Formulations and Methods of Use Thereof
US-2021177799-A1 · Jun 17, 2021 · US
Highly purified pharmaceutical grade tasimelteon
US-2021017143-A1 · Jan 21, 2021 · US
Iloperidone metabolite for use in the treatment of psychiatric disorders
US-2021015809-A1 · Jan 21, 2021 · US
Iloperidone metabolite for use in the treatment of psychiatric disorders
US-10874659-B2 · Dec 29, 2020 · US
Melatonin agonist treatment
US-2020397741-A1 · Dec 24, 2020 · US
Highly purified pharmaceutical grade tasimelteon
US-10829465-B2 · Nov 10, 2020 · US
Highly purified pharmaceutical grade tasimelteon
US-2020190048-A1 · Jun 18, 2020 · US
Highly purified pharmaceutical grade tasimelteon
US-10611744-B2 · Apr 7, 2020 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Vanda Pharmaceuticals Inc | 46 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P25/20 | 29 |
| C07D307/81 | 17 |
| C07D307/79 | 17 |
| A61K31/343 | 15 |
| A61P25/00 | 14 |